Irina A Tikhonova

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The National Institute for Health and Care Excellence (NICE) invited the manufacturer of azacitidine (Celgene) to submit evidence for the clinical and cost effectiveness of this drug for the(More)
The manufacturer of olaratumab (Lartruvo®), Eli Lilly & Company Limited, submitted evidence for the clinical and cost effectiveness of this drug, in combination with doxorubicin, for untreated(More)
  • 1